Ordinary Rebalance | Solactive Transatlantic Healthcare Equity Index | Effective Date 10th July 2023
In the ordinary rebalance, the following index composition will be implemented effective open 10.07.2023:
ABBOTT LABORATORIES |
ABBVIE INC |
ALCON INC |
AMGEN INC |
BAYER AG |
BECTON DICKINSON AND CO |
BIOGEN INC |
BIOMERIEUX |
BRISTOL-MYERS SQUIBB CO |
COLOPLAST AS CLASS B |
COOPER COMPANIES INC |
DANAHER CORP |
ELI LILLY & CO |
ENCOMPASS HEALTH CORP |
ENSIGN GROUP INC |
ESSILORLUXOTTICA |
FORTREA HOLDINGS INC |
GENMAB A/S |
GILEAD SCIENCES INC |
GSK PLC |
HOLOGIC INC |
HORIZON THERAPEUTICS PLC |
INCYTE CORP |
JAZZ PHARMACEUTICALS PLC |
JOHNSON & JOHNSON |
LABORATORY CRP OF AMER HLDGS |
MEDTRONIC PLC |
MERCK & CO. INC. |
MERIT MEDICAL SYSTEMS INC |
NOVARTIS AG |
NOVO NORDISK A/S |
PERRIGO CO PLC |
PFIZER INC |
PRESTIGE CONSUMER HEALTHCARE INC |
QIAGEN NV |
QUEST DIAGNOSTICS INC |
RECORDATI SPA |
RESMED INC |
ROCHE HOLDING AG |
ROYALTY PHARMA PLC- CL A |
SANOFI SA |
STRYKER CORP |
THE CIGNA GROUP |
THERMO FISHER SCIENTIFIC INC |
UCB SA |
UNITED THERAPEUTICS CORP |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
VIATRIS INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |